NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Vaccinia Virus



Investigators at Trinity College zero in on vaccinia virus



October 22nd, 2008

"Viruses are detected by different classes of pattern recognition receptors (PRRs), such as Toll-like receptors and RIG-like helicases. Engagement of PRRs leads to activation of interferon (IFN)-regulatory factor 3 (IRF3) and IRF7 through IKK epsilon and TBK1 and consequently IFN-beta induction," scientists writing in the Embo Journal report.

"Vaccinia virus (VACV) encodes proteins that manipulate host signalling, sometimes by targeting uncharacterised proteins. Here, we describe a novel VACV protein, K7, which can inhibit PRR-induced IFN-beta induction by preventing TBK1/IKK epsilon-mediated IRF activation. We identified DEAD box protein 3 (DDX3) as a host...


Source: Vaccine Weekly (2008-10-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login